← FDATracker
HomeAdverse Events

FENTANYL Adverse Event: Neoplasm malignant

FENTANYL Adverse Event: Neoplasm malignant is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: FENTANYL; Product category: Drug; Primary reaction: Neoplasm malignant.

Primary drugFENTANYL
Product categoryDrug
Primary reactionNeoplasm malignant
All reactionsNeoplasm malignant
SeriousnessSerious
Patient outcomeFatal
Patient sexFemale
All drugs reportedFENTANYL; ROXICODONE
Reporter countryUS
Reporter type1
Report date20140313
Report ID10007420

🔍 Search all adverse events →